296 related articles for article (PubMed ID: 10949841)
1. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
Fremaux A; Sissia G; Geslin P
Pathol Biol (Paris); 1993 Sep; 41(7):636-40. PubMed ID: 8255615
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
5. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
[TBL] [Abstract][Full Text] [Related]
6. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes.
Sener B; Köseoglu O
Int J Antimicrob Agents; 2004 Jul; 24(1):39-42. PubMed ID: 15225859
[TBL] [Abstract][Full Text] [Related]
8. Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
Pathol Biol (Paris); 1997 May; 45(5):438-40. PubMed ID: 9296100
[TBL] [Abstract][Full Text] [Related]
9. [MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Pupek J; Luczak M
Med Dosw Mikrobiol; 2006; 58(3):199-205. PubMed ID: 17340994
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.
Frédénucci I; Chomarat M; Bercion R; Carricajo A; Celard M; Croizé J; Delubac F; Fèvre D; Fuhrmann C; Helfre M; Letouzey MN; Lelièvre H; Mandjee A; Marthelet P; Meley R; Perrier-Gros-Claude JD; Ros A; Roure C; Smati S; Thierry J; Tous J
Clin Microbiol Infect; 2002 Oct; 8(10):680-3. PubMed ID: 12390289
[TBL] [Abstract][Full Text] [Related]
11. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
13. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.
Pantosti A; D'Ambrosio F; Bordi E; Scotto D'Abusco A; Del Grosso M
Clin Microbiol Infect; 2001 Sep; 7(9):503-6. PubMed ID: 11678935
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of quinupristin/dalfopristin against gram-positive bacteria Haemophilus influenzae and Branhamella catarrhalis in Taiwan.
Wang FD; Lin ML; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):433-9. PubMed ID: 10925532
[TBL] [Abstract][Full Text] [Related]
16. [Increased resistance of streptococcus pneumoniae to antibiotics and prevalence of their capsular serotypes (author's transl)].
Goldstein FW; Dang Van A; Bouanchaud DH; Acar JF
Pathol Biol (Paris); 1978; 26(3-4):173-80. PubMed ID: 28505
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to penicillin and other antimicrobials in 301 clinical isolates of Streptococcus pneumoniae].
Navarro C; Egido P; Aspiroz C; Durán E; García C; Rubio C; Gómez-Lus R
Enferm Infecc Microbiol Clin; 2000; 18(7):314-8. PubMed ID: 11109722
[TBL] [Abstract][Full Text] [Related]
18. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae in Tunisia.
Rachdi M; Boutiba-Ben Boubaker I; Moalla S; Smaoui H; Hammami A; Kechrid A; Ben Redjeb S
Pathol Biol (Paris); 2008 May; 56(3):125-9. PubMed ID: 17604572
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]